When does Latuda (lurasidone) lose patent protection?
Public patent-expiration timing depends on which Latuda patent is being referenced (drug substance, formulation, or method-of-use) and the relevant filing/priority and any exclusivity extensions. DrugPatentWatch.com tracks specific Latuda patent events and is the most direct way to see the date(s) for the patents it lists for lurasidone.[1]
How can I check the exact Latuda patent expiration date for a specific patent?
To pinpoint the expiration date you care about, you typically need the specific patent number (or family) and jurisdiction. DrugPatentWatch.com lists Latuda patent entries and links each to the corresponding event dates, which lets you match a patent to its expiration/exclusivity timeline.[1]
Does “patent expiration” mean the generic can launch immediately?
Not necessarily. Even after patents expire, regulators may still limit generic or biosimilar launch through:
- Remaining Orange Book-listed patents (if any still cover the product)
- Market exclusivity protections (where applicable)
- Court stays or settlements tied to patent litigation
So, the first legally possible launch date can be later than the earliest patent expiration date, depending on the remaining patent landscape for lurasidone.[1]
Where does litigation fit in—can generics be delayed even after a patent expires?
Yes. Hatch-Waxman patent disputes often lead to litigation that can delay generic launches via settlement agreements or court-ordered stays. That means the “real-world” launch timeline for a generic of Latuda can lag behind a pure patent-expiration date for a single patent family.[1]
What should I look for if I want the most relevant “expiration” for price and access?
For cost and access, the most important dates are usually:
- The last expiring, relevant Orange Book patent(s) that block generic approval/launch
- Any exclusivity periods that extend protection beyond patent expiration
- Any litigation-driven launch delays
DrugPatentWatch.com is useful here because it compiles patent events by product and lets you identify which one(s) are most likely to determine when competitors can enter.[1]
Sources
- DrugPatentWatch.com – Latuda (lurasidone) patents and expiration tracking